Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. MEDICAL MARIJUANA STOCKS Message Board

Exclusive: Cannabis Co. MariMed Appoints Howard Sc

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 4861
(Total Views: 200)
Posted On: 06/01/2021 5:37:04 PM
Avatar
Posted By: toodles
Exclusive: Cannabis Co. MariMed Appoints Howard Schacter To C-Suite
Javier Hasse 54 mins ago

Multi-state cannabis operator MariMed Inc. (OTCQX: MRMD) has appointed Howard Schacter as its chief communications officer, Benzinga has learned exclusively ahead of an official announcement.

Prior to joining MariMed, Schacter spent many years in the communications space, providing counsel to big companies including Facebook, Inc. (NASDAQ: FB), McDonald's Corp (NYSE: MCD), Microsoft Corporation (NASDAQ: MSFT) and Spotify Technology SA (NYSE: SPOT). Most recently, he served as the head of communications Acreage Holdings Inc (OTC: ACRHF).


“Joining MariMed at this moment is a communications leader's dream opportunity. The company has positioned itself for a great future and has a terrific story to tell. They just haven't had anyone on-board to tell it,” Schacter told Benzinga.

Bob Fireman, CEO of MariMed, added, “Howard’s unique background combines traditional corporate communications and brand marketing PR in cannabis, CPG, retail and other sectors. We are on a growth trajectory, with a focused strategic plan that’s working. Howard brings exactly the right skill set to tell our compelling MariMed story to investors and the media, to generate even more attention for our award-winning brands among customers and patients, and to align our employees around our mission and values.”

A couple weeks ago, MariMed disclosed its core revenue spiked 230% year-over-year, reaching $24.6 million in the first quarter of 2021, marking it the company's highest-ever quarter of core cannabis revenue and profitability.

In March, the company closed a $46 million financing facility with the Hadron Healthcare Fund.

https://www.msn.com/en-us/money/news/exclusiv...d=msedgntp

TOODLES






(3)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us